WINDTREE THERAPEUTICS INC /DE/ Gain (Loss) on Extinguishment of Debt
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Gain (Loss) on Extinguishment of Debt of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $74.00K.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was -$22.00K, a 100.15% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was -$154.00K.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for fiscal 2024 was $14.44M.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for fiscal 2019 was -$1.79M.
- WINDTREE THERAPEUTICS INC /DE/ gain (loss) on extinguishment of debt for fiscal 2018 was -$3.35M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-19 | $74.00K derived: sum of 2 quarters · filed 2025-11-19 | $52.00K 10-Q · filed 2025-11-19 | -$102.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | $74.00K 10-Q · filed 2025-08-19 | $52.00K 10-Q · filed 2025-08-19 | -$102.00K derived: sum of 3 quarters · filed 2025-08-19 | -$31.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | -$22.00K 10-Q · filed 2025-05-15 | -$176.00K derived: sum of 2 quarters · filed 2025-05-15 | -$105.00K derived: sum of 3 quarters · filed 2025-11-19 | -$105.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | -$154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$83.00K derived: sum of 2 quarters · filed 2025-11-19 | -$83.00K derived: sum of 3 quarters · filed 2025-11-19 | $14.44M 10-K · filed 2025-04-15 |
| 2024-09-30 | $71.00K 10-Q · filed 2025-11-19 | $71.00K derived: sum of 2 quarters · filed 2025-11-19 | $14.59M 10-Q · filed 2025-11-19 | $14.59M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-19 | $14.52M 10-Q · filed 2025-08-19 | $14.52M derived: sum of 3 quarters · filed 2025-08-19 | $14.52M derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $14.52M 10-Q · filed 2025-05-15 | $14.52M derived: sum of 2 quarters · filed 2025-05-15 | $14.52M derived: sum of 3 quarters · filed 2025-05-15 | $14.52M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 derived: sum of 3 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-26 | $0.00 derived: sum of 2 quarters · filed 2024-11-26 | $0.00 10-Q · filed 2024-11-26 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-19 | $0.00 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | |||
| 2019-12-31 | -$1.79M 10-K · filed 2021-03-29 | |||
| 2018-12-31 | -$3.35M 10-K · filed 2020-04-03 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$11.76M derived: sum of 2 quarters · filed 2017-03-31 | -$11.76M 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$11.76M 10-Q · filed 2016-11-14 | -$11.76M 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |